Taking the direct approach in hepatitis C

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.656, 2012-01, pp. : 3-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Review of direct-acting antiviral agents for the treatment of chronic hepatitis C

By Shah Nihar

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 9, 2013-09 ,pp. : 1107-1121

Informa Healthcare

Access to resources Recommend Favorite

Reply to direct-acting antiviral drugs and hepatitis C virus: A therapeutic revolution?

Cancer, Vol. 121, Iss. 23, 2015-12 ,pp. : 4269-4270

Blackwell Publishing

Access to resources Recommend Favorite

Direct-acting antiviral drugs and hepatitis C virus: A therapeutic revolution?

Cancer, Vol. 121, Iss. 23, 2015-12 ,pp. : 4268-4269

Blackwell Publishing

Access to resources Recommend Favorite

Recent Advancement of Direct-acting Antiviral Agents (DAAs) in Hepatitis C Therapy

Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 7, 2018-03 ,pp. : 584-596

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecule and Biologic Inhibitors of Hepatitis C Virus: A Symbiotic Approach

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 11, 2006-11 ,pp. : 1263-1268

Bentham Science Publishers

Access to resources Recommend Favorite